Nathan Hardy
Director of Finance/CFO at SANA BIOTECHNOLOGY, INC.
Net worth: 4 M $ as of 29/04/2024
Nathan Hardy active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Director of Finance/CFO | 31/08/2018 | - |
Career history of Nathan Hardy
Former positions of Nathan Hardy
| Companies | Position | Start | End |
|---|---|---|---|
| JUNO THERAPEUTICS INC | Director of Finance/CFO | 31/07/2017 | 31/05/2018 |
| AMGEN INC. | Director/Board Member | 31/01/2007 | 31/07/2017 |
| Corporate Officer/Principal | 31/01/2007 | 31/07/2017 |
Training of Nathan Hardy
| University of Utah | Undergraduate Degree |
| University of Notre Dame | Masters Business Admin |
Statistics
International
| United States | 6 |
Operational
| Director of Finance/CFO | 2 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Nathan Hardy
- Experience
